The Requestor is a manufacturer of two pharmaceutical products approved by the U.S. Food and Drug Administration (“FDA”) for the treatment of several different rare disorders (the “Products”).

registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.

Sangamo Therapeutics regained development and commercialization rights for its hemophilia ... after partner Pfizer conveyed its decision to terminate their collaboration. SGMO’s stock crashed ...

Known as an aptamer drug conjugate (ApDC), the next generation ... tax breaks to support their development. Announcing the FDA’s decision on Saturday, the HIM said the treatment has the ...

“The FDA approval of alfapump opens the door to a breakthrough therapeutic option for patients with ascites. This technology not only provides effective treatment but also improves quality of life.” ...

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men ... of patients treated with Gemtesa. "The FDA's expanded approval of Gemtesa is an ...

and Critical Care at the FDA’s Center for Drug Evaluation and Research. OSA is the most common form of sleep apnea and it occurs when the upper airway is blocked, leading to pauses in breathing ...

MHRA approves Merck's Winrevair ... Big Biopharma Trails Behind The Market: JP Morgan’s 2025 Outlook on Eli Lilly, Merck, and More In March 2024, the FDA approved Winrevair (sotatercept-csrk ...

Notable medicines subject to price increases include Pfizer’s COVID-19 drug Paxlovid, Bristol Myers Squibb’s CAR-T therapies Abecma and Breyanzi and a clutch of vaccines from Sanofi ...

Sangamo Therapeutics Inc.’s (SGMO) shares plummeted 56.4% after Pfizer Inc. (PFE) terminated the agreement with the company for co-developing hemophilia A gene therapy. Shares of Builders ...

After delay, Roche's Tecentriq Hybreza wins first FDA approval for a subcutaneous PD-L1 drug Opdivo Qvantig’s average administration time of less than five minutes was observed in the Checkmate ...